Instil Bio, Inc. (TIL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 20K 40K 60K Q1 '20: 44K Q2 '20: 42K Q3 '20: 52K Q4 '20: 0 Q1 '21: 0 Q2 '21: 0 Q3 '21: 0 Q4 '21: 0 Q1 '20 Q2 '20 Q3 '20 Q4 '20 Q1 '21 Q2 '21 Q3 '21 Q4 '21

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -23.6M Q4 '24: -11.8M Q1 '25: -30.6M Q2 '25: -23.4M Q3 '25: -15M Q4 '25: -9.6M Q1 '26: -7M Q2 '26: -5.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-30M -20M -10M 0 10M 20M 30M Q3 '24: -23M Q4 '24: -11.9M Q1 '25: -28.2M Q2 '25: -21.4M Q3 '25: -13.6M Q4 '25: -8.2M Q1 '26: -4.2M Q2 '26: -4.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '24: -20.1M Q4 '24: -10.6M Q1 '25: -4.2M Q2 '25: -14.8M Q3 '25: -10.6M Q4 '25: -7.1M Q1 '26: -1.3M Q2 '26: -4.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q1 '23: -43.1M Q2 '23: -26.5M Q3 '23: -19.6M Q4 '23: -13.4M Q1 '24: -14.4M Q2 '24: -10.6M Q3 '24: -20.1M Q4 '24: -10.6M Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 2.5M 5M 7.5M Q1 '24: 6.5M Q2 '24: 6.5M Q3 '24: 6.5M Q1 '25: 6.5M Q2 '25: 6.6M Q3 '25: 6.8M Q1 '26: 6.8M Q2 '26: 6.8M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q3 '24: -11.56 Q4 '24: -11.39 Q1 '25: -11.97 Q2 '25: -12.92 Q3 '25: -11.39 Q4 '25: -10.74 Q1 '26: -7.04 Q2 '26: -4.43 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.